The companies will jointly offer services and equipment solutions for the development, high-volume manufacture, and launch of multiplexed in vitro diagnostics.
The firms will collaborate on creating and co-marketing array technologies for research and clinical diagnostics.
The partners will develop multiplex tests to detect human pathogens in 75 minutes on Grenier's PCR-based Genspeed Test System.
The partners will launch the alliance by developing a colorimetric reader system for multiplexed lateral flow microarrays.
The partners will combine the sciFlexarrayer with Anteo's reagents to improve the functionality and shelf-life of activated glass and polymer slides and other arrays.
QuantuMDx will use Scienion's ultra-low-volume liquid handling technologies in its Q-Poc handheld molecular diagnostic device.
NEW YORK (GenomeWeb) — Scienion and Genomica today announced the CE IVD marking and launch of their jointly developed multiplex molecular assay for sexually transmitted infections.
NEW YORK (GenomeWeb) – The Institute for Global Food Security, MBio Diagnostics, and Scienion today announced they will combine their technologies to create tools to monitor marine toxins.
NEW YORK (GenomeWeb) – The AIT Austrian Institute of Technology, BioVendor, and Scienion announced today a partnership to develop an in vitro diagnostic test for the early detection of colon cancer.
NEW YORK (GenomeWeb) – Scienion is hoping its participation in a unique research project will help raise awareness for a microarray-based test for water quality monitoring.
Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.
University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.
The Wall Street Journal examines billing codes used by uBiome.
In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.